| First Author | Yun HM | Year | 2014 |
| Journal | Oncogene | Volume | 33 |
| Issue | 44 | Pages | 5193-200 |
| PubMed ID | 24858037 | Mgi Jnum | J:217025 |
| Mgi Id | MGI:5612931 | Doi | 10.1038/onc.2014.128 |
| Citation | Yun HM, et al. (2014) Loss of presenilin 2 is associated with increased iPLA2 activity and lung tumor development. Oncogene 33(44):5193-200 |
| abstractText | Presenilins are the enzymatic components of gamma-secretase complex that cleaves amyloid precursor protein, Notch and beta-catenin, which has critical roles in the development of Alzheimer's disease and cancer cell growth. Therefore, in the present study, we studied the effects and mechanisms of PS2 knockout on lung cancer development and possible mechanisms as a key regulator of lung tumor development. We compared carcinogen-induced tumor growth between PS2 knockout mice and wild-type mice. PS2 knockout mice showed increased urethane (1 mg/g)-induced lung tumor incidence when compared with that of wild-type mice with decreased activity of gamma-secretase in the lung tumor tissues. Consequently, iPLA2 activities in lung tumor tissues of PS2 knockout mice were much higher than in tumor tissues of wild-type mice. Furthermore, knockdown of PS2 using PS2 siRNA decreased gamma-secretase activity with increased iPLA2 activity in the lung cancer cells (A549 and NCI-H460), leading to increased lung cancer cell growth. PS2 knockout mice and PS2 knockdown lung cancer cells showed increased DNA-binding activities of nuclear factor kappa-beta, signal transducer and activator of transcription 3 (STAT3) and AP-1 which are critical transcriptional factors of iPLA2 than those of PS2 wild-type mice and control lung cancer cells. Taken together, these results suggest that the loss of PS2 could have a critical role in lung tumor development through the upregulation of iPLA2 activity by reducing gamma-secretase. |
